First: Roche- CIPLA Antibody Cocktail of Casirivimab and Imdevimab for mild to moderate COVID-19 now available in India Ruchika Sharma24 May 2021 2:44 PM ISTThe antibody cocktail (Casirivimab and Imdevimab) is to be administered for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in...
Roche Tecentriq Pivotal Phase III data shows hope for cancer patients Ruchika Sharma20 May 2021 11:00 AM ISTBasel: Roche today announced interim results from the Phase III IMpower010 study, showing for the first time that treatment with Tecentriq...
Roche India gets CDSCO nod to COVID antibody cocktail of Casirivimab, Imdevimab Ruchika Sharma6 May 2021 2:00 PM ISTThe drug will be available through leading hospitals and COVID treatment centres, Roche India said.
Roche to acquire GenMark Diagnostics for USD 1.8 billion Ruchika Sharma16 March 2021 1:18 PM ISTBasel: Roche and GenMark Diagnostics have recently announced that they have entered into a definitive merger agreement for Roche to fully acquire...
Roche obtains CE mark for SARS-CoV-2 Rapid Antigen Test Nasal Ruchika Sharma2 Feb 2021 2:30 PM ISTBesides being less invasive, the test also provides patients with the option to self-collect their nasal sample under the supervision of a healthcare...
Narendra Varde appointed as Roche Diagnostics Managing Director India, Neighbouring Markets Ruchika Sharma15 Jan 2021 12:14 PM ISTNew Delhi: Roche Diagnostics India, a part of the Roche Group, on Wednesday announced the appointment of Narendra Varde as Managing Director for...
Roche, Sanofi arthritis drugs Actemra, Kevzara respectively reduce death rates among sickest COVID patients: Study Ruchika Sharma9 Jan 2021 9:00 AM ISTLondon: Treating critically ill COVID-19 patients with Roche's Actemra or Sanofi's Kevzara arthritis drugs significantly improves survival rates and...
Roche gets European Commission nod for Phesgo to treat HER2-positive breast cancer Ruchika Sharma27 Dec 2020 9:15 AM ISTPhesgo is available as a single-dose vial for SC injection and enables over 90% faster treatment than IV administration of standard of care therapy...
Roche launches cobas PIK3CA Mutation Test for advanced or metastatic breast cancer Ruchika Sharma17 Dec 2020 12:00 PM ISTThe cobas PIK3CA Mutation Test detects 17 mutations in the PIK3CA gene and can help clinicians identify patients who may benefit from phosphoinositide...
Roche Pharma unveils pan tumor liquid biopsy test in India Ruchika Sharma19 Nov 2020 11:49 AM ISTMumbai: Roche Products (India) Pvt. Ltd. (Roche Pharma India) has recently announced the launch of FoundationOneLiquid CDx, Foundation Medicine's...
Roche, Atea Pharma join hands to develop potential oral treatment for COVID-19 Ruchika Sharma25 Oct 2020 9:15 AM ISTBasel: Roche and Atea Pharmaceuticals, Inc. have recently announced that they are joining forces in the fight against COVID-19 to develop, manufacture...
Roche confirms 2020 outlook as Covid-19 diagnostics surge Ruchika Sharma16 Oct 2020 9:00 AM ISTZurich: The frantic global effort to test people for Covid-19 pushed Roche's diagnostics division to record revenue, helping the Swiss drugmaker...
